Al-Sadawi Mohammed, Tao Michael, Zhang David, Wanamaker Brett L, Deshmukh Amrish, Ghannam Michael, Bogun Frank, Liang Jackson J
University of Michigan Hospital, 1500 E Medical Center Dr, Ann Arbor, MI 48109, United States of America.
Stony Brook University Hospital, 101 Nicolls Rd, Stony Brook, NY 11794, United States of America.
Cardiovasc Revasc Med. 2025 Mar;72:81-85. doi: 10.1016/j.carrev.2024.11.006. Epub 2024 Nov 19.
Coronary chronic total occlusion (CTO) can result in ischemic cardiomyopathy which may create substrate supportive of ventricular arrhythmias (VA). The purpose of this meta-analysis is to evaluate the association of CTOs with risk of ventricular arrhythmias (VAs) and to assess the utility of CTO percutaneous coronary intervention (PCI) in this setting.
A literature search was conducted for studies reporting an association between CTOs and VAs and PCI VAs among patients with CTO. VAs were defined as ventricular tachycardia, ventricular fibrillation, sudden cardiac death, and appropriate implantable cardiac defibrillator therapy. The search included the following databases: Ovid MEDLINE, EMBASE, Web of Science, and Google Scholar. The search was not restricted to time or publication status.
Nine studies with 3068 participants (1405 with CTOs and 1663 with coronary artery disease [CAD]) met inclusion criteria. CTOs were associated with significantly higher risk of VAs compared with patients with CAD without CTOs (OR 2.25, 95 % CI 1.92-2.64; p < 0.01). Three studies with 1830 patients with CTOs (970 revascularized, 860 on optimal medical therapy) met inclusion criteria for evaluating the association of CTO revascularization and VAs. CTO PCI was associated with a significantly lower risk of VAs compared with patients treated with optimal medical therapy.
Patients with CTOs appear to have a higher burden of VAs compared with patients with CAD without CTOs. Revascularization of CTOs was found to be associated with significant reduction in risk of VAs, however additional high-quality studies are required to further evaluate this association.
冠状动脉慢性完全闭塞(CTO)可导致缺血性心肌病,这可能会形成支持室性心律失常(VA)的基质。本荟萃分析的目的是评估CTO与室性心律失常风险之间的关联,并评估CTO经皮冠状动脉介入治疗(PCI)在此情况下的效用。
对报告CTO与VA之间关联以及CTO患者PCI与VA关联的研究进行文献检索。VA被定义为室性心动过速、室颤、心源性猝死以及合适的植入式心脏除颤器治疗。检索包括以下数据库:Ovid MEDLINE、EMBASE、科学网和谷歌学术。检索不受时间或发表状态的限制。
9项研究共3068名参与者(1405名患有CTO,1663名患有冠状动脉疾病[CAD])符合纳入标准。与无CTO的CAD患者相比,CTO与显著更高的VA风险相关(比值比2.25,95%置信区间1.92 - 2.64;p < 0.01)。3项研究共1830名CTO患者(970名接受血运重建,860名接受最佳药物治疗)符合评估CTO血运重建与VA关联的纳入标准。与接受最佳药物治疗的患者相比,CTO PCI与显著更低的VA风险相关。
与无CTO的CAD患者相比,CTO患者似乎有更高的VA负担。发现CTO血运重建与VA风险显著降低相关,然而需要更多高质量研究来进一步评估这种关联。